Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Appointments

Set Alert for Appointments

Latest From Appointments

Appointments: Changes At Hikma, Bluebird Bio, Celgene, Alkermes, Cell Medica, Editas Medicine, Futura Medical, Corline Biomedical And Horizon Discovery

Pharma and biotech appointments this week include a new CEO at Hikma and an interim-CEO at Horizon Discovery, a Chief Commercial Officer for bluebird bio, and new board directors at Celgene, Alkermes, Editas Medicine, and Futura Medical.

Appointments Companies

Appointments: Changes At Axovant Sciences, Immunocore, Sangamo Therapeutics, Circassia, MaxCyte and CANbridge Life Sciences

Pharma and biotech appointments this week include a management shake up at Axovant Sciences, a new CEO at Immunocore, Sangamo's latest legal hire, and new board members at Circassia and MaxCyte.
Appointments BioPharmaceutical

Asia Movers To Watch: Astellas, Kyowa Hakko, CMIC, CFDA

February brings new executives at Japan's Astellas, Kyowa Hakko Bio and CMIC. Meanwhile, China FDA deputy commissioner has departed to become the head of an influential academic organization.

Appointments Asia Pacific

Appointments: Stada, Astellas, Novo Nordisk, Boehringer Ingelheim, Dova, Selvita, Orchard, MannKind, Cancer Genetics

The latest biopharma industry appointments include CEOs for Stada and Astellas, a finance chief for Novo Nordisk and a new president for Boehringer Ingelheim in the US, while Orchard Therapeutics has made a key addition to its scientific advisory board.

Appointments BioPharmaceutical

Asia Executives To Watch: Aslan, CanBridge, Sosei, Wuxi NextCode

The New Year brings in new executive moves including a new China GM for ASLAN a new CMO for Sosei, while CanBridge and WuXi NextCode have appointed new VPs.

Appointments Asia Pacific

Appointments: Celgene, Merck KGaA, Ipsen, Ablynx, Advicenne, Dragonfly, Ritter And The ABPI

Company personnel changes in the past week include the CEO of Celgene adding to his responsibilities with the role of chairman, a new CIO at Merck KGaA, new CMOs at Ipsen and Dragonfly Therapeutics, and new CSOs at Ablynx and the ABPI. Vice presidents of clinical development have been named at Advicenne and Ritter Pharmaceuticals.

Appointments BioPharmaceutical

Appointments: Sanofi, MSD, Pandion, Orchard, Redx, Glythera, Inotrem

Companies filling positions include Sanofi, with a new head of business transformation, and MSD Research Laboratories, with a leader for its new London early discovery facility. There is new leadership for Pandion Therapeutics, and further C-suite appointments at Orchard Therapeutics, Redx Pharma, Glythera and Inotrem.

Appointments Leadership

Appointments: Hikma, Ipsen, PeptiDream, Targovax, Moderna and Perrigo

The latest biopharma industry appointments include C-suite hires at Hikma, Ipsen, Sinclair PeptiDream, Targovax, Nicox, Moderna, Antabio and Perrigo; as well as a supervisory board appointment at Kiadis.

Appointments BioPharmaceutical

Asia Executives To Watch: GSK, Kyowa Hakko, PeptiDream

The coming of the new year has brought a flurry of executive changes. GSK Japan has a new president, Kyowa Hakko Kirin a new CEO, while the deputy commissioner of China's national health regulator has departed.

Appointments Asia Pacific

Novartis Finds All-Important Head Of Oncology Business At Pfizer

Novartis has tempted Liz Barrett away from Pfizer to become CEO of Novartis Oncology, but the appointment of a new global drug development head at the Swiss multinational has yet to be announced.

Appointments Cancer

Appointments: Oculis, PellePharm, Syntimmune, Sterna Biologicals, Proclara Biosciences, Denovo Biopharma and OrphoMed

The latest biopharma industry appointments include new CEOs at Oculis, PellePharm, Syntimmune and Sterna Biologicals and a new CFO at Oculis, as well as new CMOs at Proclara Biosciences, Denovo Biopharma and OrphoMed.

Appointments BioPharmaceutical

Appointments: Neurotrope, Concert, Lannett, Peregrine, Allergan, Amneal, Acticor, Alliance Pharma

The latest biopharma industry appointments include new CEOs at Neurotrope, Lannett, Amneal and Peregrine Pharmaceuticals, a new CFO at Concert Pharmaceuticals, a new EVP of global operations at Allergan, a new CMO at Acticor, and a US country manager for Alliance Pharma.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register